About
I tell stories about biotech builders and influencers and their efforts to improve the…
Articles by Matthew
Activity
-
Outsourced Pharma is honored to present the winners of the 14th annual #CDMOLeadershipAwards, determined by the customers who use their services to…
Outsourced Pharma is honored to present the winners of the 14th annual #CDMOLeadershipAwards, determined by the customers who use their services to…
Liked by Matthew Pillar
-
My recent videocast convo with Chief Medical Officer Thomas Heineman at Oncolytics Biotech Inc. brought to mind a recurring dream in which I am…
My recent videocast convo with Chief Medical Officer Thomas Heineman at Oncolytics Biotech Inc. brought to mind a recurring dream in which I am…
Liked by Matthew Pillar
-
I'm excited to be attending BioProcess International US West 2025 this March!🌴 #BioProcessInternational #BPI #Bioprocessing #SanDiego Informa…
I'm excited to be attending BioProcess International US West 2025 this March!🌴 #BioProcessInternational #BPI #Bioprocessing #SanDiego Informa…
Liked by Matthew Pillar
Experience
Education
Projects
-
Business of Biotech Newsletter
Love the Business of Biotech Podcast? You'll love the NEW Business of Biotech newsletter. Once a month. Ad Free. Insight from the leading minds in emerging biopharma. Subscribe at www.bioprocessonline.com/bob
More activity by Matthew
-
Francisco Conesa Buendía (Memorial Sloan Kettering Cancer Center) says the decision to adopt a centralized or decentralized model is influenced by…
Francisco Conesa Buendía (Memorial Sloan Kettering Cancer Center) says the decision to adopt a centralized or decentralized model is influenced by…
Liked by Matthew Pillar
-
🚀 Aumni is live at HIMSS 2025 in Las Vegas! 🚀 We're thrilled to be part of HIMSS 2025, connecting with healthcare and technology leaders to…
🚀 Aumni is live at HIMSS 2025 in Las Vegas! 🚀 We're thrilled to be part of HIMSS 2025, connecting with healthcare and technology leaders to…
Liked by Matthew Pillar
-
I'm thrilled to announce that my first article for Bioprocess Online is now live! Huge thanks to Jon O'Connell for his invaluable support and to all…
I'm thrilled to announce that my first article for Bioprocess Online is now live! Huge thanks to Jon O'Connell for his invaluable support and to all…
Liked by Matthew Pillar
-
Outsourced Pharma is honored to present the winners of the 14th annual #CDMOLeadershipAwards, determined by the customers who use their services to…
Outsourced Pharma is honored to present the winners of the 14th annual #CDMOLeadershipAwards, determined by the customers who use their services to…
Liked by Matthew Pillar
-
Rothwell Figg's Dan Shores is back for the third and final installment of our Advancing RNA series on the wild world of mRNA patent litigation…
Rothwell Figg's Dan Shores is back for the third and final installment of our Advancing RNA series on the wild world of mRNA patent litigation…
Liked by Matthew Pillar
-
Owen Hughes and Brad Sitko sat down with Matthew Pillar for an extended conversation during JPMorgan’s Healthcare Conference. The discussion focused…
Owen Hughes and Brad Sitko sat down with Matthew Pillar for an extended conversation during JPMorgan’s Healthcare Conference. The discussion focused…
Liked by Matthew Pillar
-
Tessera Therapeutics Advances In Vivo Gene Therapy For SCD https://lnkd.in/e-hnfTGk "We aim to revolutionize care by developing a one-time in vivo…
Tessera Therapeutics Advances In Vivo Gene Therapy For SCD https://lnkd.in/e-hnfTGk "We aim to revolutionize care by developing a one-time in vivo…
Liked by Matthew Pillar
-
From safety considerations to #rarediseases and RMAT designations and more, Sidley Austin LLP Emily Marden and Kelly Cho recap the significant FDA…
From safety considerations to #rarediseases and RMAT designations and more, Sidley Austin LLP Emily Marden and Kelly Cho recap the significant FDA…
Liked by Matthew Pillar
-
We hear all the time about the ability of AI/ML-assisted technologies and processes to improve and expedite drug development, including clinical…
We hear all the time about the ability of AI/ML-assisted technologies and processes to improve and expedite drug development, including clinical…
Liked by Matthew Pillar
-
Cell & Gene Therapies: Will 2025 Represent A Continuation Of FDA's 2024 Developments? https://lnkd.in/eAwZzYjV - By Emily Marden and Kelly Cho…
Cell & Gene Therapies: Will 2025 Represent A Continuation Of FDA's 2024 Developments? https://lnkd.in/eAwZzYjV - By Emily Marden and Kelly Cho…
Liked by Matthew Pillar
-
At first glance, Steven Erb at Crown Point Biotech Consulting LLC says there's nothing in FDA's recent draft guidance on 21 CFR 211.110 compliance…
At first glance, Steven Erb at Crown Point Biotech Consulting LLC says there's nothing in FDA's recent draft guidance on 21 CFR 211.110 compliance…
Liked by Matthew Pillar
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Matthew Pillar in United States
-
Matthew Pillar
Freelance Business owner
-
Matthew Pillar
Veterans Service Officer at Brookings County, South Dakota
-
Matthew Pillar
(CWI) QA/QC Inspector
-
Matthew Pillar
Construction Project Manager at Walker Family Construction
16 others named Matthew Pillar in United States are on LinkedIn
See others named Matthew Pillar